Post-approval studies (Phase 4)UnknownNCT06093451
What this trial is testing
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
Who this might be right for
Schizophrenia AgitationSchizo Affective DisorderBipolar Disorder+1 more
Temple University 32